A doctor has explained the main symptoms of a new coronavirus variant known as Arcturus which is rapidly spreading around the world. At least five people are thought to have died with the strain ...
Hosted on MSN1mon
Arcturus Therapeutics names Moncef Slaoui as Chair DesignateSAN DIEGO - Arcturus Therapeutics (NASDAQ:ARCT) Holdings Inc. (NASDAQ: ARCT), a company specializing in mRNA medicines for infectious diseases and rare disorders, has appointed Dr. Moncef Slaoui ...
“Arcturus has deep expertise in mRNA delivery for therapeutics and a validated commercial stage vaccines platform,” said Dr. Moncef Slaoui. “I am excited to work with the company during this ...
Thank you, operator. Good afternoon, and welcome to Arcturus Therapeutics quarterly financial update and pipeline progress call. Today's call will be led by Joe Payne, our President and CEO; and Andy ...
Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...
Dr. Slaoui is currently on the Company’s Board of Directors, a position he has held since June 2024. Arcturus’ primary revenue streams include license fees, consulting and related technology ...
“Arcturus continues to make excellent progress ... Ph.D., as Chair Designate. Dr. Slaoui is currently on the Company’s Board of Directors, a position he has held since June 2024.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback